An open letter to @PersonalisInc$PSNL and @TempusAI$TEM leadership and boards
Absolutely amazing news from Merck and Moderna on their positive Phase 3 melanoma personalized cancer vaccine (PCV) trial. The market rewarded $MRK and $MRNA with a combined $50B+ increase in